Companies Directory

The Institute of Mine Seismology (IMS) is the largest independent research organisation focused on developing methodologies, technologies and services for monitoring and managing the seismic rock mass response to mining. The 45 staff of the IMS have qualifications that include 8 PhD, 10 MSc and 17 Bachelor degrees with a collective 300 years of experience in this field. IMS currently supports over 210 customers in 34 countries. There are over 60 active IMS seismic monitoring systems in Australia, 70 in South Africa and at least 80 in the rest of the world. In 2010, the IMS bought the businesses and assets of ISS International and ISS Pacific.

Since 1975, the Institute of Modern Art has been the hub of Brisbane’s contemporary art scene, presenting an annual program of exhibitions, public programs, publications, and offsite programs by Queensland, Australian, and international artists. Through our artistic programs, which include exhibitions, publications, offsite projects, and public programs, we invest in the local, shape the national, and impact the international. Our vision is to amplify voices, ignite curiosity, and inspire change through contemporary art by championing new art, artists, and ideas. Entry to our exhibitions is always free. Open Tuesday–Sunday, 10am–5pm and Thursday, 10am–8pm.

Dr. Diego de Mendoza arrived to Rosario in 1985, invited by the then Dean of the Faculty of Pharmacy and Biochemistry, Dr. Juan Carlos Leon, to form the area of Basic Microbiology. Although, at that time, there was a lack of financial resources and equipment, it was possible to bring together researchers such as Néstor Carrillo, Alejandro Viale and Eduardo Ceccarelli, with the aim to carry out high standard science. Gradually, laboratories were equipped with the first grants until in 1985 PROMUBIE (Multidisciplinary Experimental Biology Program) was formed. Then, in 1999,IBR arose, and later consolidated as a joint Institute of CONICET and the National University of Rosario. Finally, in 2012 IBR moved to its first own building on the campus of CONICET Rosario. The history of IBR and its initial achievements , united by the passionate enthusiasm of doing science internationally, has shown that, with conviction and a strong spirit of solidarity, dreams can be achieved. Nowadays, IBR has numerous internationally recognized researchers; among them are researchers from the Howard Hughes Medical Institute and the National Institute of Health, both from U.S.

At the Institute of Molecular and Clinical Ophthalmology Basel (IOB), basic researchers and clinicians work hand in hand to advance the understanding of vision, its diseases and to develop new therapies for vision loss. The institute is constituted as a foundation. IOB started operations in 2018. At IOB, we accelerate the conversion of basic research into innovative treatments which change the field of ophthalmic therapy. Interdisciplinary teams of researchers and clinicians work hand in hand. These problem-solvers and innovators have in-depth knowledge of unmet medical needs, and daily exposure to patients. Together, they improve the understanding of vision, and of the cells involved in eye disease. In this highly collaborative environment, IOB turns discoveries and technologies into clinical benefits for patients with blinding conditions. We help advance the practice of ophthalmic disease based on the genetic, structural and functional understanding of the cell types and their interactions within the human eye. At the Institute of Molecular and Clinical Ophthalmology Basel (IOB), basic researchers and clinicians work hand in hand to advance the understanding of eye diseases and to develop new therapies for vision loss.

At the Institute of Molecular and Clinical Ophthalmology Basel (IOB), basic researchers and clinicians work hand in hand to advance the understanding of vision, its diseases and to develop new therapies for vision loss. The institute is constituted as a foundation. IOB started operations in 2018. At IOB, we accelerate the conversion of basic research into innovative treatments which change the field of ophthalmic therapy. Interdisciplinary teams of researchers and clinicians work hand in hand. These problem-solvers and innovators have in-depth knowledge of unmet medical needs, and daily exposure to patients. Together, they improve the understanding of vision, and of the cells involved in eye disease. In this highly collaborative environment, IOB turns discoveries and technologies into clinical benefits for patients with blinding conditions. We help advance the practice of ophthalmic disease based on the genetic, structural and functional understanding of the cell types and their interactions within the human eye. At the Institute of Molecular and Clinical Ophthalmology Basel (IOB), basic researchers and clinicians work hand in hand to advance the understanding of eye diseases and to develop new therapies for vision loss.

IMB is a research centre of excellence in Mainz, Germany. Our international scientists focus on developmental biology, epigenetics and genome stability. Imprint/Impressum: https://www.imb.de/de/impressum/

IMBA - Institute of Molecular Biotechnology is one of the leading biomedical research institutes in Europe focusing on cutting-edge functional genomics and stem cell technologies. IMBA is located at the Vienna Biocenter, the vibrant cluster of universities, research institutes and biotech companies in Austria. IMBA is a basic research institute of the Austrian Academy of Sciences, the leading national sponsor of non-university academic research.

The Institute of Navigation (ION) is the world's premier non-profit professional society advancing Positioning, Navigation and Timing (PNT). Founded in 1945, it serves a diverse community including those interested in air, space, marine, land navigation, and position determination. Its membership is worldwide, and it is affiliated with the International Association of Institutes of Navigation. The ION sponsors an International Technical Meeting Co-Located with the Precise Time and Time interval Systems Applications Meeting (PTTI) (January), IEEE/ION PLANS (Spring - Even Years), ION Pacific PNT (Spring - Odd Years), ION Military Division's Joint Navigation Conference (JNC) (Spring), and ION GNSS+ Meeting (September). These conferences provide a chance to present technical papers and discuss new findings with industry peers. The ION is well known for is its prestigious peer-reviewed and indexed quarterly journal, NAVIGATION. The journal publishes original, peer-reviewed articles on all areas related to the science and technology of air, sea, land and space navigation, including estimation of position, velocity, attitude, and time, and the technologies that support the determination of these quantities. Supporting technologies include navigation aids and instrumentation, algorithms and methods, error and integrity analysis, signal processing, biological navigation systems, surveying and geodesy. Editorial services for the journal are provided by professionals in government, industry, and academia.

The main fundamental and applied investigations include: clarifying the relationship between the synthesis, the structure and the reactivity of organic compounds; isolation, determination of the structure and practical application of natural compounds; determination of the structure and the function of proteins, enzymes and peptides; study of the thermal and catalytic transformations of hydrocarbons.

The main fundamental and applied investigations include: clarifying the relationship between the synthesis, the structure and the reactivity of organic compounds; isolation, determination of the structure and practical application of natural compounds; determination of the structure and the function of proteins, enzymes and peptides; study of the thermal and catalytic transformations of hydrocarbons.